Neuronal Ceroid Lipofuscinosis are a group of devastating neurodegenerative lysosomal storage disorders that begin in childhood. Mutations in CLN3 gene lead to a NCL called Batten disease, characterized by the progressive loss of vision, movement, and cognition.
‘Optimizing R&D structure is also on the horizon, without exception,’ new Sumitomo Pharma CEO says
Sumitomo Pharma CEO Toru Kimura says that he sees the need to streamline the company’s business and product lineup, and is considering steps including job
July 3, 2024